These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11365288)

  • 41. Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program.
    McKenzie M; Macalino G; McClung C; Shield DC; Rich JD
    J Opioid Manag; 2005; 1(3):147-51. PubMed ID: 17315418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The paradox of control: An ethnographic analysis of opiate maintenance treatment in a Norwegian prison.
    Mjåland K
    Int J Drug Policy; 2015 Aug; 26(8):781-9. PubMed ID: 26025481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001.
    Strike CJ; Urbanoski K; Fischer B; Marsh DC; Millson M
    J Addict Dis; 2005; 24(1):39-51. PubMed ID: 15774409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of HIV infection in provincial prisons in British Columbia.
    Rothon DA; Mathias RG; Schechter MT
    CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey.
    Greer AM; Hu S; Amlani A; Moreheart S; Sampson O; Buxton JA
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():3. PubMed ID: 26762162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada.
    Voon P; Greer AM; Amlani A; Newman C; Burmeister C; Buxton JA
    Harm Reduct J; 2018 Jul; 15(1):35. PubMed ID: 29976203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.
    Harris A; Selling D; Luther C; Hershberger J; Brittain J; Dickman S; Glick A; Lee JD
    Subst Abus; 2012; 33(1):70-5. PubMed ID: 22263715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of the Chinese police in methadone maintenance therapy: a literature review.
    Meng J; Burris S
    Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methadone treatment is widely accepted in prisons in New South Wales.
    Byrne A; Dolan K
    BMJ; 1998 Jun; 316(7146):1744-5. PubMed ID: 9614035
    [No Abstract]   [Full Text] [Related]  

  • 54. The Case for Medication for Opioid Use Disorder during Incarceration as Standard of Care.
    Tamburello A
    J Am Acad Psychiatry Law; 2022 Dec; 50(4):502-508. PubMed ID: 36535785
    [No Abstract]   [Full Text] [Related]  

  • 55. Opioid addiction and incarceration: an overview.
    Schwartz RP; McKenzie M; Rich JD
    Med Health R I; 2007 May; 90(5):157-8. PubMed ID: 17557660
    [No Abstract]   [Full Text] [Related]  

  • 56. Methadone maintenance treatment in prisons: The New South Wales Experience.
    Hall W; Ward J; Mattick R
    Drug Alcohol Rev; 1993; 12(2):193-203. PubMed ID: 16818329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comment on "An overview of illegal opioid use and health services utilization in Canada" by S. Popova, J. Rehm, B. Fischer.
    Gatherer A
    Public Health; 2006 Nov; 120(11):1090; author reply 1091. PubMed ID: 16876214
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].
    Popov P; Becka J; Wilczek H
    Vnitr Lek; 2003 Nov; 49(11):851-8. PubMed ID: 14689681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Injecting drug use in prison: prevalence and implications for needle exchange policy.
    Wright NM; Tompkins CN; Farragher TM
    Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.